Hematocrit is a ratio rather than a count, so anything that shifts plasma volume moves it too. The practical job after a flagged result is to work out whether the red cell mass is truly increased, and if it is, what is driving it. This guide covers the common causes, the rarer ones, how a clinician separates them, and the follow-up tests that usually come next.
Hematocrit is the share of total blood volume made up of red blood cells, reported as a percentage. Most modern analyzers calculate it from the red cell count and the average red cell size rather than spinning blood in a tube, which is why it tracks closely with hemoglobin on the same report. Because it is a ratio of cells to total volume, two very different situations raise it. More red cells in the same plasma raises it, and the same red cells in less plasma raises it as well. The fuller picture of what the marker is, how it is measured, how ranges shift with age and sex, and what a low value may reflect sits on the Hematocrit guide. This page stays on the causes of a high result.
A hematocrit is called high when it sits above the upper limit of the reference range printed on your own report, and it is taken seriously when it stays above that limit on a repeat sample. A single borderline value is a signal to look again, not a conclusion.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Hematocrit, adults | 36 to 52% | 40 to 50% |
| Hematocrit, women | 33 to 48% | 36 to 44% |
These are typical lab reference ranges, and they vary by laboratory, analyzer, age, sex and the altitude a population lives at, so your report's own range always comes first. The optimal ranges shown are optimization targets, not diagnostic cut-offs, and a value sitting just outside an optimal band is not the same thing as an abnormal result.
Several ordinary factors shift where a person normally sits. Men generally run higher than women because of androgen effects on red cell production. Pregnancy expands plasma volume and tends to lower the reading. People living at altitude run higher as a group. None of that makes a rising trend unimportant, but it does mean the number is read against the person, not against a single universal line.
Yes, and this is the first thing a careful clinician rules out. Hematocrit is sensitive to how much plasma is in circulation at the moment the sample is drawn, so a reading taken after a long run, a sauna, a night of poor fluid intake, heavy alcohol the evening before or a morning without water can sit higher than the same person's steady state.
Collection technique matters too. A tourniquet left on for a long time, a sample drawn after the person has been standing rather than seated, and the natural daily swing in plasma volume all nudge the result. For that reason, a value flagged as high is usually repeated on a separate day, with normal hydration and a standard draw, before anything else is ordered. Reviews of the diagnostic approach to erythrocytosis suggest that confirming the result is persistent is the necessary first step before any specialist testing is considered 1.
What this means in practice is simple. One high number on one morning tells you to retest. The same number three weeks later, drawn properly, tells you something real is happening and is worth investigating with a clinician.
This is the single most useful fork in the road, and clinicians split high results into two families. Relative or apparent erythrocytosis means the red cell mass is normal but plasma volume has contracted, so the cells make up a larger share. Absolute erythrocytosis means the body really is producing more red cells.
Relative patterns show up with acute dehydration, vomiting, diarrhea, burns, heavy sweating and ongoing use of fluid-removing medication. There is also a longer-standing version described in people who carry extra weight around the middle, drink regularly, smoke and have raised blood pressure, where the plasma volume sits chronically at the low end. The reading is genuinely elevated, but the marrow is behaving normally.
Absolute erythrocytosis is divided again. Primary means the problem is in the marrow itself, where red cell precursors multiply without the usual signal. Secondary means the marrow is responding correctly to an outside signal, almost always erythropoietin, the hormone the kidneys release when they sense low oxygen. Published diagnostic frameworks indicate that separating relative from absolute, then primary from secondary, is what organizes the whole workup 1.
In most people with a mildly raised reading, the cause is something ordinary and identifiable rather than rare. The usual suspects cluster into a short list.
Under-hydration and fluid loss top it, because they are common, they are easy to create accidentally with hot weather, endurance training or a low fluid intake, and they resolve between one draw and the next. Smoking and other sources of carbon monoxide come next. Carbon monoxide binds hemoglobin tightly and reduces the oxygen it can carry, so the body compensates by making more red cells, and the reading climbs over months rather than days. Living or training at altitude does the same thing through a different route, by lowering the oxygen available in each breath.
Obstructive sleep apnea is a frequent and often unrecognized contributor, because repeated overnight oxygen dips drive the same hormonal response while the person sleeps through it. Carrying substantial excess weight can reduce overnight oxygen levels even without classic apnea. Regular alcohol intake and long-term use of fluid-removing medication both tend to lower plasma volume. And testosterone therapy, whether prescribed or obtained elsewhere, is one of the most consistent medication-related reasons a previously normal reading starts climbing.
None of these is a diagnosis on its own. They are the questions a clinician asks first because they explain the majority of mildly raised values.
Low oxygen raises hematocrit through a sensing system in the kidneys. Specialized cells there monitor oxygen delivery, and when it falls, a family of oxygen-sensitive transcription factors escapes the enzymes that normally degrade it. That triggers release of erythropoietin, which tells the bone marrow to produce more red cells. More red cells mean more oxygen carried per unit of blood, which is a sensible short-term adaptation.
The list of things that lower oxygen delivery is long. Altitude is the cleanest example. Chronic lung conditions that impair gas exchange belong here, as do conditions where blood bypasses the lungs, such as certain congenital heart shunts. Obstructive sleep apnea and obesity-related overnight hypoventilation count because the dips happen at night, when nobody is measuring. Chronic carbon monoxide exposure from smoking or an unventilated appliance counts because the oxygen is in the blood but cannot be released properly. Inherited hemoglobin variants that hold onto oxygen too tightly produce the same signal despite a normal oxygen saturation reading on a fingertip monitor.
Reviews of secondary erythrocytosis indicate that hypoxia-driven causes make up the bulk of absolute cases outside the marrow disorders, and that overnight oxygen measurement is often more informative than a single daytime reading 2. This is also why a normal clinic oxygen saturation does not close the question.
Several medication classes are recognized as causes, and because they are reversible in principle, clinicians ask about them early. Androgen and testosterone therapies are the best known, since androgens stimulate red cell production directly and also influence iron availability. Erythropoiesis-stimulating agents raise red cell production by design. Sodium-glucose cotransporter 2 inhibitors, used in metabolic and kidney care, are associated with a rise in hematocrit partly through plasma volume reduction. Long-term fluid-removing medication produces a relative rise rather than a true increase in red cell mass. Some over-the-counter and performance products sold outside normal supply chains contain androgenic compounds that are never declared on the label.
A systematic review of drug-induced erythrocytosis found that the pattern is recognized across several drug classes and that recognizing the responsible agent is central to how clinicians approach the case 3. That review describes a clinical phenomenon rather than a rule for any individual.
Two points matter here. First, no one should stop, start or alter a prescribed medication based on a web page. A licensed provider evaluates whether a therapy remains appropriate, whether monitoring needs to change and what the alternatives are. Second, an honest medication and supplement list, including anything bought online, saves a great deal of unnecessary testing.
Polycythemia vera is a chronic bone marrow disorder in which red cell production continues independently of the normal erythropoietin signal. It belongs to the primary group, and it is the main reason a persistently raised hematocrit gets investigated properly rather than watched.
The pattern looks different from the secondary causes. Erythropoietin tends to be low or low-normal rather than high, because the marrow is not responding to a signal, it is generating cells on its own. White cells and platelets are often raised alongside the red cells. The spleen may be enlarged. Some people describe itching after a warm shower, a symptom distinctive enough that clinicians ask about it directly. An acquired mutation in the JAK2 gene is present in the large majority of cases, which is why JAK2 testing sits so early in the workup.
Not every unexplained raised result is this, and not every negative JAK2 test ends the question. A 2026 update on JAK2 unmutated erythrocytosis describes a group of people with persistent absolute erythrocytosis in whom no mutation and no secondary driver is found, a category that research suggests needs ongoing follow-up rather than a one-time conclusion 4. A hematologist decides what label, if any, fits, and management belongs entirely to that clinician.
Yes, and these causes share one mechanism, inappropriate erythropoietin production. The kidneys make the hormone, so kidney tissue that is structurally abnormal can release too much of it even when oxygen delivery is adequate.
The best-described version appears after kidney transplantation, where a sustained rise in red cell mass can develop in the months to years following the procedure. Certain cystic kidney changes and renal artery narrowing can do something similar. A review of erythrocytosis in kidney disease indicates that the picture is more varied than the older model of kidney failure causing only anemia, and that a raised hematocrit in kidney care warrants its own assessment 5.
A small number of tumors produce erythropoietin or an erythropoietin-like signal. Kidney cancers, liver cancers, certain brain tumors of the cerebellum, some uterine fibroids and rare adrenal and parathyroid tumors have all been described in this context. Reviews of secondary erythrocytosis suggest these causes are uncommon but are the reason abdominal imaging appears on the workup list when the hormone level is unexpectedly high and no hypoxic cause is found 2.
This is also the part of the topic most likely to cause unnecessary alarm. A mildly raised value in a smoker who skipped breakfast and water is not this. A persistently raised value with a high erythropoietin level and no obvious oxygen problem is what prompts imaging.
It can, and congenital causes are worth considering in people whose values have been high since youth, who have affected relatives, or in whom the standard workup finds nothing. These conditions are rare, but they are well characterized.
They split into two groups. In the first, the red cell precursors are oversensitive to the normal signal, classically through changes in the erythropoietin receptor, which produces a primary pattern with a low hormone level. In the second, the oxygen-sensing pathway itself is altered, so the body behaves as though it is short of oxygen when it is not. Changes affecting the von Hippel-Lindau gene, the oxygen-sensing enzymes and the hypoxia-inducible transcription factors sit here, as do hemoglobin variants with unusually high oxygen affinity and the rare enzyme deficiency that reduces 2,3-bisphosphoglycerate.
Published reviews of congenital erythrocytosis describe these as a small but genuine share of otherwise unexplained cases, with family history and lifelong elevation as the most useful clues 6. Earlier reviews of congenital polycythemias set out the same two-group framework 7, and laboratory reviews indicate that measuring the oxygen affinity of hemoglobin, often reported as p50, helps identify the high-affinity variants that routine testing misses 8.
By working through a sequence rather than ordering everything at once. The history does most of the early work, covering smoking, altitude, snoring and daytime sleepiness, medications and supplements, alcohol, breathlessness, kidney history and family history. Then a confirmed repeat sample, then targeted tests chosen by what the history suggested.
| Follow-up test | What it helps separate |
|---|---|
| Repeat complete blood count | Relative or transient rise versus a persistent one |
| Serum erythropoietin | Low points toward a marrow-driven cause, high or normal toward a secondary one |
| JAK2 V617F, then exon 12 if negative | Polycythemia vera from the other causes |
| Oxygen saturation, overnight oximetry or a sleep study | Hypoxia-driven causes, including sleep apnea |
| Carboxyhemoglobin | Smoking and other carbon monoxide exposure |
| Ferritin and iron studies | Iron depletion that often accompanies a raised red cell mass |
| Kidney function and abdominal imaging | Kidney, liver and other erythropoietin-producing causes |
| Hemoglobin oxygen affinity and targeted genetic testing | Inherited causes when the standard workup is negative |
An education review of JAK2 wild-type erythrocytosis indicates that a structured stepwise differential, rather than a broad panel ordered at once, is what keeps the workup efficient and avoids over-investigation 9. A review of algorithmic evaluation for hereditary causes found that these pathways have real caveats, including hormone levels that do not always fall where the textbook predicts 10. Direct red cell mass measurement exists but is used rarely and only in specialist settings.
Hematocrit is far more informative inside a panel than on its own. Hemoglobin and red cell count move with it and confirm the direction. Mean cell volume, mean cell hemoglobin and red cell distribution width describe the cells themselves, and small, pale cells alongside a high hematocrit often point toward iron being consumed by increased production. Ferritin, serum iron and transferrin saturation complete that picture.
Platelets and white cells matter because a rise across all three lines looks different from a rise in red cells alone. Kidney function through creatinine and estimated filtration rate is relevant to both the kidney causes and the overall picture. Erythropoietin is the pivot test when a persistent rise has been confirmed. Testosterone, where relevant, connects a rising reading to a therapy or an underlying hormonal pattern. Blood pressure, fasting glucose or HbA1c and a lipid panel round out the metabolic context that often accompanies the low plasma volume pattern.
Seeing these together is the argument for broad, repeated panels rather than single tests. FitScript's membership includes 150+ biomarkers tested per year, with results interpreted by Atlas, its AI health advisor, so a marker like this is read as a trend across a full panel rather than as an isolated number on one morning.
Often none at all, which is why most raised readings are found on a routine panel rather than because someone felt unwell. When symptoms do appear, they are non-specific and overlap with many ordinary causes.
People sometimes report headache, dizziness, a flushed or ruddy complexion, blurred vision, ringing in the ears, fatigue or reduced exercise tolerance. Itching after a warm shower or bath is reported less often but is specific enough that clinicians ask about it. Numbness or burning in the hands and feet is described in some marrow-driven cases. Symptoms related to the underlying cause can be more revealing than the hematocrit itself, so loud snoring, witnessed pauses in breathing, morning headache and daytime sleepiness point one way, while breathlessness on exertion points another.
The useful way to read this is in three steps. The observation is a raised percentage of red cells. The possible meaning is either less plasma or more red cells, with a cause behind whichever it is. The next step is a repeat sample and a conversation with a clinician who can match the number to your history, rather than self-interpreting a single result.
Because blood that carries a higher proportion of cells is thicker, and thicker blood flows less easily through small vessels. A persistently raised red cell mass is associated with increased blood viscosity and with a higher risk of clotting events, which is the main clinical reason the finding is investigated rather than observed indefinitely. That association is strongest and best studied in the marrow-driven causes.
The degree of concern depends heavily on the cause, how high the value is, how long it has been there and what else is present, including blood pressure, smoking status, prior clots and other cardiovascular factors. A mildly raised reading in a well person that normalizes on a properly hydrated repeat sample carries a very different weight from a persistently raised one with a low erythropoietin level. Diagnostic reviews indicate that persistence plus an absolute increase in red cell mass is what moves a result from observation into investigation 1.
What is not appropriate is self-management. Deciding whether anything needs to change, and what, requires knowing the cause. That decision sits with a clinician, not with a number.
Any result flagged above your lab's reference range is worth raising at your next appointment, and a result that stays high on a repeat sample is worth a planned conversation rather than a wait-and-see. Bring the actual report, the full medication and supplement list, your smoking status, your altitude history and anything your household has noticed about your breathing at night.
Some situations are worth discussing with a clinician promptly rather than at the next routine visit. Those include a markedly raised value, a raised value alongside raised platelets or white cells, new or worsening breathlessness, chest pain, one-sided leg swelling or pain, severe or unusual headache, visual changes, or new weakness, numbness or speech difficulty. Those last symptoms warrant urgent medical attention in their own right, regardless of what the blood count shows.
This article is educational and is not medical advice. Discuss your own results, and any treatment decision that follows from them, with a clinician or licensed provider who can evaluate your full history and examine you.
Yes. Hematocrit is the proportion of blood volume made up of red cells, so losing plasma through sweating, poor fluid intake, vomiting, diarrhea or alcohol concentrates a normal number of red cells and raises the percentage. This is called relative or apparent erythrocytosis. It typically resolves on a repeat sample drawn on a separate day with normal hydration, which is why clinicians almost always retest before ordering anything further.
It can. Repeated drops in oxygen overnight trigger the kidneys to release erythropoietin, which signals the bone marrow to produce more red cells. Because the dips happen during sleep, a normal daytime oxygen reading in clinic does not rule it out, and overnight oximetry or a sleep study is often the test that clarifies it. Loud snoring, witnessed breathing pauses, morning headache and daytime sleepiness are worth mentioning to a clinician.
Androgens stimulate red cell production directly and also influence iron availability for that production, so a rising hematocrit is one of the recognized laboratory changes monitored during androgen or testosterone therapy. A systematic review of drug-induced erythrocytosis describes this pattern across several drug classes. Nobody should adjust or stop a prescribed therapy based on a web page. A licensed provider evaluates whether the therapy remains appropriate and how monitoring should change.
No. Polycythemia vera is one possible cause among many, and most mildly raised readings turn out to reflect low plasma volume, smoking, altitude, overnight low oxygen or a medication. Polycythemia vera usually shows a different pattern, often with a low erythropoietin level, raised platelets or white cells and a JAK2 mutation. Only a clinician, after a confirmed repeat result and targeted testing, can determine what a persistent elevation represents.
Both can, through different routes. A hard training session or a hot day lowers plasma volume temporarily and raises the reading for hours, which is a transient effect. Living or training at altitude lowers the oxygen available in each breath, so the body increases red cell production over weeks to months, which is a genuine increase in red cell mass. A clinician factors altitude history into how your result is read.
A serum erythropoietin level is the usual pivot test, because a low level points toward a marrow-driven cause while a normal or high level points toward a secondary one. JAK2 testing, oxygen saturation or overnight oximetry, carboxyhemoglobin, iron studies, kidney function and sometimes abdominal imaging follow, chosen according to what the history suggests rather than ordered all at once.
Yes, and it is one of the more common contributors. Carbon monoxide from smoke binds hemoglobin tightly and reduces the oxygen it can deliver, so the body compensates by producing more red cells over months. Smoking also tends to lower plasma volume, so both mechanisms push in the same direction. A carboxyhemoglobin measurement can show the exposure, and the reading often falls after sustained cessation, though timing varies by person.
That is not a decision to make independently. Removing blood changes the number without addressing the cause, can deplete iron, and may obscure the pattern a clinician needs to see in order to work out what is driving the result. Whether any intervention is appropriate, and what kind, depends on the underlying cause and is decided by a clinician after the workup, not before it.